These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34197865)

  • 1. Stability of p53 oligomers: Tetramerization of p53 impinges on its stability.
    Luwang JW; Nair AR; Natesh R
    Biochimie; 2021 Oct; 189():99-107. PubMed ID: 34197865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function.
    Lubin DJ; Butler JS; Loh SN
    J Mol Biol; 2010 Jan; 395(4):705-16. PubMed ID: 19913028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated p53 tetramerization domain mutants: quantitative analysis reveals a low threshold for tumor suppressor inactivation.
    Kamada R; Nomura T; Anderson CW; Sakaguchi K
    J Biol Chem; 2011 Jan; 286(1):252-8. PubMed ID: 20978130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational detection of p53's oligomeric state by FlAsH Fluorescence.
    Webber TM; Allen AC; Ma WK; Molloy RG; Kettelkamp CN; Dow CA; Gage MJ
    Biochem Biophys Res Commun; 2009 Jun; 384(1):66-70. PubMed ID: 19393630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tandem dimerization of the human p53 tetramerization domain stabilizes a primary dimer intermediate and dramatically enhances its oligomeric stability.
    Poon GM; Brokx RD; Sung M; Gariépy J
    J Mol Biol; 2007 Jan; 365(4):1217-31. PubMed ID: 17113101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligomerization of the tetramerization domain of p53 probed by two- and three-color single-molecule FRET.
    Chung HS; Meng F; Kim JY; McHale K; Gopich IV; Louis JM
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6812-E6821. PubMed ID: 28760960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers.
    van Dieck J; Fernandez-Fernandez MR; Veprintsev DB; Fersht AR
    J Biol Chem; 2009 May; 284(20):13804-13811. PubMed ID: 19297317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.
    D'Abramo M; Bešker N; Desideri A; Levine AJ; Melino G; Chillemi G
    Oncogene; 2016 Jun; 35(25):3272-81. PubMed ID: 26477317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of methionine residue at hydrophobic core destabilizes p53 tetrameric structure.
    Nomura T; Kamada R; Ito I; Chuman Y; Shimohigashi Y; Sakaguchi K
    Biopolymers; 2009 Jan; 91(1):78-84. PubMed ID: 18781628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing phenylalanine environments in oligomeric structures with pentafluorophenylalanine and cyclohexylalanine.
    Nomura T; Kamada R; Ito I; Sakamoto K; Chuman Y; Ishimori K; Shimohigashi Y; Sakaguchi K
    Biopolymers; 2011 Jun; 95(6):410-9. PubMed ID: 21280026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 oligomerization status modulates cell fate decisions between growth, arrest and apoptosis.
    Fischer NW; Prodeus A; Malkin D; Gariépy J
    Cell Cycle; 2016 Dec; 15(23):3210-3219. PubMed ID: 27754743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative binding of tetrameric p53 to DNA.
    Weinberg RL; Veprintsev DB; Fersht AR
    J Mol Biol; 2004 Aug; 341(5):1145-59. PubMed ID: 15321712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tetramerization domain of the tree shrew p53 protein displays unique thermostability despite sharing high sequence identity with the human p53 protein.
    Nakagawa N; Sakaguchi S; Nomura T; Kamada R; Omichinski JG; Sakaguchi K
    Biochem Biophys Res Commun; 2020 Jan; 521(3):681-686. PubMed ID: 31690451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations.
    Fadda E; Nixon MG
    Phys Chem Chem Phys; 2017 Aug; 19(32):21287-21296. PubMed ID: 28597880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding.
    Patel S; Bui TT; Drake AF; Fraternali F; Nikolova PV
    Biochemistry; 2008 Mar; 47(10):3235-44. PubMed ID: 18260640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 tetramerization: at the center of the dominant-negative effect of mutant p53.
    Gencel-Augusto J; Lozano G
    Genes Dev; 2020 Sep; 34(17-18):1128-1146. PubMed ID: 32873579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.
    Jeffrey PD; Gorina S; Pavletich NP
    Science; 1995 Mar; 267(5203):1498-502. PubMed ID: 7878469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers.
    Rajagopalan S; Jaulent AM; Wells M; Veprintsev DB; Fersht AR
    Nucleic Acids Res; 2008 Oct; 36(18):5983-91. PubMed ID: 18812399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for allosteric effects on p53 oligomerization induced by phosphorylation.
    Muller P; Chan JM; Simoncik O; Fojta M; Lane DP; Hupp T; Vojtesek B
    Protein Sci; 2018 Feb; 27(2):523-530. PubMed ID: 29124793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysines in the tetramerization domain of p53 selectively modulate G1 arrest.
    Beckerman R; Yoh K; Mattia-Sansobrino M; Zupnick A; Laptenko O; Karni-Schmidt O; Ahn J; Byeon IJ; Keezer S; Prives C
    Cell Cycle; 2016 Jun; 15(11):1425-38. PubMed ID: 27210019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.